"This conference will provide important exposure as we continue building a significant customer base for blood-based biomarker services in Alzheimer's disease, with the ultimate shared goal of improving the current standard of care used to treat AD."
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links